Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Short communication · 21 May 2022Exact title match Conference abstract · 2017 Plastin3 as a therapeutic target in spinal muscular atrophy
Spinal muscular atrophy (SMA) is a devastating childhood motor neuron disease caused by mutations in the survival motor neuron 1 gene (SMN1). SMN1 and SMN2 are nearly identical genes producing
Review article · 2017 Mutation Spectrum of Survival Motor Neuron Gene in Spinal Muscular Atrophy
Spinal muscular atrophy (SMA) is an autosomal recessive disease and characterized by symmetrical muscle weakness. All types of SMA are the result of mutations in survival motor neuron (SMN1) gene
Research article · 17 Oct 2014 Morphological changes and altered expression of antioxidant proteins in a heterozygous dynein mutant; a mouse model of spinal muscular atrophy
increased evidence that oxidative stress is involved in exacerbations of neurodegenerative diseases and spinal muscular atrophies. Methods: We examined changes in morphology and expression of antioxidant proteins and…
Editorial · 23 Nov 2021 Brief Description of the Spinal Muscular Atrophy
Review article · 31 Jan 2022 Genetics of Spinal Muscular Atrophy and Splicing of Smn Gene
Spinal muscular atrophy is characterized by loss of motor neurons and muscle atrophy, largely in childhood. It is a devastating neuromuscular disorder. In humans, nearly two identical inverted SMN genes ... SMN2 gene…
Research article · Dec 2010 Results of surgical treatment of spine deformities in patients with spinal muscular atrophy type II and type III
Introduction. Spinal muscular atrophy (SMA) is a group of hereditary diseases that manifests in weakness and flaccid paresis, marked mostly in lower limbs and proximal rather than distal muscle groups ... postoperative…
Case report · 20 Jun 2016 Homozygous Point Mutation in a Patient with Spinal Muscular Atrophy Type 1
Spinal muscular atrophy (SMA) is an autosomal recessive disease with progressive hypotonia and muscle atrophy resulting from degeneration of the anterior horn cells in the spinal cord and the brain
Review article · 2020 Advances and limitations for the Treatment of Spinal Muscular Atrophy
Spinal Muscular Atrophy (5q-SMA;SMA) is a genetic neuromuscular condition effecting spinal motor neurons. SMA is caused by a defect in both copies of the SMN1 gene that produces
Conference abstract · 3 Mar 2020 Molecularly targeted therapy for spinal muscular atrophy (SMA) and duchene muscular dystrophy (DMD): Kuwait experience
Spinal muscular atrophy (SMA) is an autosomal recessive, motor neuron disease caused by progressive degeneration of motor neurons in the entire spinal cord and in select brainstem motor nuclei (nuclei ... disorder…
Case report · 2017 Valproic Acid Treatment for Spinal Muscular Atrophy Patient with Abnormal Electroencephalogram Findings
histone deacetylase inhibitor that can increase the Survival Motor Neuron (SMN) level in Spinal Muscular Atrophy (SMA) patients and anticipated to be an effective therapeutic agent for SMA. Patient description
Case report · 2015 Molecular Genetic Diagnosis for a Family with Type I Spinal Muscular Atrophy (SMA) via Analysis of the Survival Motor Neuron (SMN) Gene
Autosomal recessive spinal muscular atrophy (SMA) is, after cystic fibrosis, the second most common fatal monogenic disorder. Depending on the clinical type, SMA causes early death or increasing disability
Conference abstract · 30 Dec 2021 Role of Gene replacement therapy in children have infantile and later-onset spinal muscular atrophy (SMA): survival, motor function, motor milestone, clinical endpoints, and safety profile
Spinal muscular atrophy (SMA) is a neurodegenerative disease involving the deletion ofthe SMN1 gene. Traditional treatment is primarily supportive. In 2019, the FDA approved gene therapy in children to improve…
Short communication · 26 Feb 2020 Molecularly targeted therapy for Duchene Muscular Dystrophy (DMD) and Spinal Muscular Atrophy (SMA): Kuwait Experience
Spinal muscle atrophy (SMA) is an autosomal recessive motor neuron disease caused
Conference abstract · 24 Jul 2017 A novel approach to SMN protein-based evaluation as biomarker in spinal muscular atrophy
Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease caused by deletion or mutation within the survival motor neuron 1 (SMN1) gene, leading to progressive limb and trunk muscle ... associated…
Conference abstract · 21 Jul 2014 Characterization of a spinal muscular atrophy Drosophila model
Spinal Muscular Atrophy (SMA) is a devastating rare genetic disease (1/6000) caused by loss of α-motor neurons of the spinal cord and brainstem nuclei. SMA is primarily caused
Conference abstract · 16 Oct 2017 Defining Conserved Spinal Muscular Atrophy Gene Networks that is are Involved in Neuromuscular system using Drosophila SMA model
Spinal Muscular Atrophy (SMA) is a devastating inherited disorder characterized by progressive loss of motor activity, failure of neuromuscular synapses and muscle weakness. Genetic cause of SMA is mutation ... factor…
Conference abstract · 24 Jul 2017 Imaging flow cytometry for identifying differences in SMN protein expression between spinal muscular atrophy patients and normal subjects
Background: Childhood spinal muscular atrophy (SMA) is a common autosomal recessive disorder caused by mutations of the survival motor neuron 1 (SMN 1) gene, leading to progressive muscle weakness
Conference abstract · 18 Mar 2019 Assessment of awareness of the early clinical features of Spinal Muscular Atrophy (SMA) amongst pediatricians
Background: Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease characterized by progressive atrophy of the voluntary muscles of the limbs and trunk. The rarity of SMA along with
Conference abstract · 2019 The expression of SMN1, MART3, GLE1 and FUS genes in spinal muscular atrophy
Introduction: Spinal muscular atrophy (SMA) is one of the most common genetic causes of death in infants due to a mutation of the motor neuron 1 (SMN1) gene. The SMN1
Conference abstract · 2020 Spinal Muscular Atrophy- Emerging therapies and future directions
Spinal Muscular Atrophy (SMA) is a very severe neurodegenerative disease which causes progressive muscle atrophy and weakness due to loss of the anterior horn cells in the spinal cord
Conference abstract · 2017 Defining conserved spinal muscular atrophy gene networks that are involved in neuromuscular system using Drosophila SMA model
Spinal Muscular Atrophy (SMA) is a devastating inherited disorder characterized by progressive loss of motor activity, failure of neuromuscular synapses and muscle weakness. Genetic cause of SMA is mutation ... factor…
Research article · 22 May 2017 Molecular analysis of the SMN gene mutations in spinal muscular atrophy patients in China
Spinal muscular atrophy (SMA) is one of the most common autosomal recessive diseases. Survival motor neuron1 (SMN1) is the SMA disease-determining gene. We examined the molecular basis
Review article · 3 May 2019 SMN2 Gene Based Treatments In Spinal Muscular Atrophy- A Review Of Recent Advancements
Spinal muscle atrophy (SMA) is a neurodegenerative disease with autosomal recessive inheritance
Editorial · 31 May 2024 Analyzing Macrostructural Brain Abnormalities in Spinal Muscular Atrophy
pinal Muscular Atrophy (SMA) is a genetic neuromuscular disorder caused by mutations in the SMN1 (Survival Motor Neuron 1) gene, which leads to a deficiency of the SMN protein. This ... deficiency affects motor neurons…

